Cancer Med
Antineoplastic Combined Chemotherapy ProtocolsDrug-Related Side Effects and Adverse ReactionsErbB Receptors
Dr. Russell Foster Devore III, MD
NPI1952301459
- Medicare services, 2020
- 12,535
- Part D claims, 2020
- 138
- Publications
- 5
- Clinical trials
- 4
- Industry payments
- $843
- Practice address
- 9700 Tunbridge Ln, Knoxville, TN 37922-3426
- Practice phone
- Call (655) 989-5543
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Devore's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Russell Foster Devore III is a hematologist and oncologist in Knoxville, Tennessee
Dr. Devore practices in Knoxville, Tennessee.
Dr. Devore's NPI, 1952301459, was assigned on July 26, 2005. Dr. Devore holds Tennessee license MD0000018111.
NPI and contact details
- NPI
- 1952301459NPI Registry (opens in a new tab)
- NPI enumeration date
- July 26, 2005
- NPI status
- Active
- Practice phone
- (655) 989-5543
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Russell Foster Devore III's practice address is in Knoxville, Tennessee
Dr. Devore's practice address in the NPI Registry is 9700 Tunbridge Ln, Knoxville, TN 37922-3426. The practice phone is (655) 989-5543.
- NPI Registry address9700 Tunbridge Ln, Knoxville, TN 37922-3426Phone(655) 989-5543
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Russell Foster Devore III's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devore practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Devore's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Devore practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Russell Foster Devore III is one of 271 hematologists and oncologists in Tennessee
Hematology and oncology is Dr. Devore's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Devore's licenses on file in 2 states: Tennessee and Kentucky.
Specialties and state licenses
- Hematology and oncology, TennesseePrimary
- Kentucky license
Hematologists and oncologists near Dr. Devore
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Russell Foster Devore III billed Medicare for 12,535 services in 2020
CMS data shows 12,535 Medicare services from Dr. Devore across 16 procedure codes in 2020. Medicare paid $37,156 for them. Every service was in an office.
Medicare services, 202012,535
Paid by Medicare$37,156
Procedure codes16
Dr. Devore's Medicare services by type, 2019 to 2020
- 2019
- 2020
- Other services
- 2019: 19,4872020: 11,22042%
- Lab and pathology
- 2019: 1,5472020: 64658%
- Surgery
- 2019: 4902020: 22953%
- Tests and treatments
- 2019: 5282020: 21859%
- Office and hospital visits
- 2019: 4772020: 19659%
- Drugs given in the office
- 2019: 2,7542020: 2699%
Dr. Devore compared with the Tennessee median for hematologists and oncologists, 2020
- Dr. Devore
- Tennessee median
- Medicare services
- 12,535vs 81815.3 times
- Part D claims
- 138vs 50873% below
Medians across 259 hematologists and oncologists in Tennessee with Dmand AI profiles that report each measure.
Dr. Devore's most billed Medicare procedure codes, 2020
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Devore?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Devore and other hematologists and oncologists in Tennessee.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Russell Foster Devore III's patients have a median age of 71
Across all payers, Dmand AI patient panel data puts Dr. Devore's median patient age at 71, with 30% women.
Dr. Devore's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women30%
- Men70%
Source: Dmand AI Patient Panel Data
Dr. Russell Foster Devore III wrote 138 Medicare Part D claims in 2020
In 2020, Dr. Devore wrote 138 Medicare Part D claims. They cover 6 drugs, with $346,495 in total drug cost. In 2019, CMS named 224 claims across 10 drugs.
Part D claims, 2020138
Drugs named by CMS6
Total drug cost$346,495
Dr. Devore's most prescribed drugs by claims, 2020
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2019 to 2020
- 2019
- 2020
- Claims for drugs CMS names
- 2019: 2242020: 13838%
Drugs named by CMS: 6 in 2020, 10 in 2019.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Devore by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Russell Foster Devore III has 5 publications on record
Dmand AI links 5 papers to Dr. Devore, published from 2004 to 2014. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols and Lung Neoplasms. Dr. Devore's most frequent co-authors are Louis Fehrenbacher, MD, Laura Williams Goff, MD and David M. Jablons, MD.
Papers5
Years published2004 to 2014
Dr. Devore's papers by year, 2004 to 2014
Topics Dr. Devore writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Lung Neoplasms
Dr. Devore's most frequent co-authors
- Louis Fehrenbacher, MD1 shared paper
- Laura Williams Goff, MD1 shared paper
- David M. Jablons, MD1 shared paper
Recent publications by Dr. Devore
Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy Protocols
Alkyl and Aryl TransferasesCarcinoma, Small CellFarnesyltranstransferase
See who Dr. Devore researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Devore works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Russell Foster Devore III has worked on 4 clinical trials
Dmand AI links Dr. Devore to 4 clinical trials. Conditions studied include Carcinoma, Bronchogenic, Small Cell Lung Carcinoma and Carcinoma, Non-Small-Cell Lung.
Conditions in Dr. Devore's trials
- Carcinoma, Bronchogenic
- Small Cell Lung Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Neoplasm Metastasis
- Neoplastic Processes
Investigators on the most trials with Dr. Devore
- David Allen Smith, MD2 shared trials
- Roy Timothy Webb, MD2 shared trials
- Glen Weiss, MD2 shared trials
Recent clinical trials with Dr. Devore
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) (opens in a new tab)
CompletedPhase 1/2
Small Cell Lung CarcinomaCarcinoma, BronchogenicCarboplatinEtoposideTrilaciclib
Neoplasm MetastasisNeoplastic ProcessesMSB0011359C
Small Cell Lung CarcinomaCarcinoma, BronchogenicDinutuximabIrinotecanTopotecan
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC (opens in a new tab)
No longer available
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicLDK378
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Russell Foster Devore III received $843 in industry payments from 2016 to 2021
CMS Open Payments shows 57 general payments to Dr. Devore from 21 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 93% of the total. Celgene Corporation paid the most, $180. It also lists 9 research payments totaling $495 in 2019.
General payments to Dr. Devore by program year, 2016 to 2021
General payments to Dr. Devore by kind, 2016 to 2021
$843in total
- Food and beverage$78893%
- Education$567%
Companies that paid Dr. Devore the most, 2016 to 2021
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Russell Foster Devore III's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Russell Foster Devore III
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Russell Foster Devore III's NPI number?
Dr. Russell Foster Devore III's NPI number is 1952301459. It was assigned on July 26, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Russell Foster Devore III?
Dr. Russell Foster Devore III is a hematologist and oncologist in Knoxville, Tennessee. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Russell Foster Devore III practice?
Dr. Devore practices at 9700 Tunbridge Ln, Knoxville, TN 37922-3426.
What is Dr. Russell Foster Devore III's office phone number?
The practice phone on file for Dr. Devore is (655) 989-5543.
What is Dr. Russell Foster Devore III's medical license number?
Dr. Devore holds Tennessee license MD0000018111, one of the licenses on file in 2 states.
Which states has Dr. Russell Foster Devore III been licensed in?
Dmand AI has state licenses on file for Dr. Devore in Tennessee and Kentucky.
Does Dr. Russell Foster Devore III accept Medicare?
Yes. CMS data shows Dr. Devore billed Medicare for 12,535 services in 2020.
What services does Dr. Russell Foster Devore III bill to Medicare?
In 2020, Dr. Devore's most billed Medicare services were medicare temporary code (Q0138), surgery: heart and blood vessels (36415) and lab and pathology test (85025).
What drugs does Dr. Russell Foster Devore III prescribe most?
In 2020 Medicare Part D data, Dr. Devore's most prescribed drugs by claims were Anastrozole, Oxycodone HCl and Imbruvica.
Has Dr. Russell Foster Devore III received payments from drug or device companies?
CMS Open Payments shows $843 in general payments to Dr. Devore from 21 companies from 2016 to 2021. The largest total came from Celgene Corporation.
Show 3 more questionsShow fewer questions
How long has Dr. Russell Foster Devore III been practicing?
Dr. Devore's NPI was assigned in 2005.
Does Dr. Russell Foster Devore III do research?
Dmand AI links 5 publications to Dr. Devore, published from 2004 to 2014. Dr. Devore has worked on 4 clinical trials.
Who does Dr. Russell Foster Devore III publish with?
Dr. Devore's most frequent co-authors are Louis Fehrenbacher, MD (1 shared paper), Laura Williams Goff, MD (1 shared paper) and David M. Jablons, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Tennessee by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card